Skip to main content
Clinical Trials/NCT07312201
NCT07312201
Not yet recruiting
Not Applicable

Oral Nutritional Supplementation in Children With Growth Concerns: A Randomized, Controlled Single-blinded Study

Société des Produits Nestlé (SPN)0 sites216 target enrollmentStarted: September 30, 2026Last updated:

Overview

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Société des Produits Nestlé (SPN)
Enrollment
216
Primary Endpoint
Assess the effect of ONS coupled with dietary counseling on growth in children

Overview

Brief Summary

Multi-center, single-blinded, randomized, controlled study consisting of two arms, to investigate the impact of an oral nutritional supplement in combination with dietary counseling on growth in children with growth concerns as compared to children who receive dietary counselling alone

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Other
Masking
Single (Participant)

Eligibility Criteria

Ages
24 Months to 41 Months (Child)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Child's parent(s) is of legal age of majority (18 years of age), must understand the informed consent form and other relevant study documents, and is willing and able to fulfill the requirements of the study protocol.
  • Evidence of a personally signed and dated informed consent document indicating that the child's parent(s) / legally acceptable representative (LAR) has been informed of all pertinent aspects of the study.
  • Child was full-term at birth (i.e., ≥ 37 completed weeks of gestation with a birth weight of ≥ 2.5 kg and ≤ 4.5 kg).
  • Child is aged 24 - 41 months at inclusion.
  • Child is generally healthy (acute illnesses in a minor condition which are common in childhood such as viral or bacterial infections (e.g., conjunctivitis, otitis media, upper/lower respiratory tract infection, gastroenteritis, hand foot \& mouth disease) at time of enrolment is permitted).
  • Children whose parents, caregivers, or guardians show some concern about their child's dietary intakes and growth, such as child is too thin for his or her height, or child has experienced recent rapid weight loss or failure to gain weight or height and child has a z-score for weight-for-age or weight-for-height or both parameters ≤ -1SD as per WHO growth charts.
  • Child's parents agree to feed their child an oral nutritional supplement in addition to normal diet.
  • Child's parent(s) / guardian can be contacted directly by telephone throughout the study.

Exclusion Criteria

  • Child is currently breastfed or is consuming breast milk.
  • Child is currently consuming or consumed in the past month growing-up milk / toddler formula. Growing-up milks / toddler formulas are products specifically formulated for young children and provide key macro- and micro-nutrients.
  • Child is currently consuming or consumed in the past month oral nutrition supplement (ONS). The standard ONS formula has an energy density of at least 0.85 kcal/mL, containing protein, carbohydrate and/or fat, as well as a wide range of micronutrients to supplement or use as the sole source of nutrition.
  • Child has known or suspected cows' milk protein intolerance / allergy, lactose intolerance, galactosemia, soy intolerance / allergy, fish oil intolerance / allergy, or allergy or intolerance to any ingredient in the study product.
  • Child fed vegan, vegetarian, or vegetarian plus fish diets in which milk products are excluded.
  • Underlying medical illness that could affect growth or feeding, such as gastrointestinal \[GI\] disorders (such as celiac disease, short bowel syndrome, maldigestion/malabsorption, significant GI malformations or surgery etc.); neurodevelopmental disability; chronic infections (such as tuberculosis or HIV infection); congenital disease or genetic disorders (such as congenital cardiac disease, Down syndrome, thalassemia); or other chronic illness that may impact growth or feeding according to the clinician opinion.
  • Child is unable to consume foods or ONS orally (e.g. dysphagia, anorexia, difficulty in swallowing due to acquired or congenital abnormalities that would hamper oral intake of the study product.)
  • Clinically significant nutritional deficiency requiring specific nutritional therapy other than the study product (for example tube feeding)
  • Child has acute illness including acute viral infection, respiratory tract infection etc. even in a minor condition at time of enrolment. A child presenting with an acute illness can be re-screened at least two weeks after the episode of illness has resolved.
  • Child has a z-score for weight-for-height or weight-for-age or height-for-age or any combination of these three parameters ≤ -3SD as per WHO growth charts.

Outcomes

Primary Outcomes

Assess the effect of ONS coupled with dietary counseling on growth in children

Time Frame: Day 1 to Day 169

Change in weight-for-age z score

Secondary Outcomes

  • Physical strength of children(Day 1 to Day 169)
  • Blood marker of longitudinal growth(Day 1 to Day 169)
  • Weight of growing children(Day -7 to Day 169)
  • Length/height of growing children(Day -7 to Day 169)
  • Mid-upper arm circumference of growing children(Day -7 to Day 169)
  • Body mass index (BMI) of growing children(Day -7 to Day 169)
  • Z-scores and percentiles(Day -7 to Day 169)
  • Nutrient intake of children(Day 1 to Day 169)
  • Bone mass index of children(Day 1 to Day 169)
  • Skeletal muscle mass of children(Day 1 to Day 169)
  • Blood markers of bone turnover(Day 1 to Day 169)
  • Product satisfaction of children and parents(Day 14 to Day 169)
  • Parental perceptions on appetite, growth, level of activity and sleep of children(Day 1 to Day 169)
  • Duration of illness and absence from pre-school due to illness(Time Frame: Day -7 to Day 169)
  • Concomitant medications and treatments(Day -7 to Day 169)
  • Blood markers of nutritional status(Day 1 to Day 169)
  • Cognitive Functioning(Day 169)
  • Safety assessment (Adverse Events)(Day -7 to Day 169)

Investigators

Sponsor
Société des Produits Nestlé (SPN)
Sponsor Class
Industry
Responsible Party
Sponsor

Similar Trials